Bafna Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs)
Bafna Pharmaceuticals Ltd · Outcome · 11 Nov 2026, 10:16 pm
Bafna Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakhs) ■ Revenue: 4,767 (+34.4% YoY | +79.3% QoQ) ■ EBITDA: 860 (+100.9% YoY | +875.6% QoQ) ■ EBITDA Margin (%): 18.0 (+597 bps YoY | +1473 bps QoQ) ■ PAT: 685 (+119.1% YoY | +9018.8% QoQ) ■ EPS (INR): 2.89 (+118.9% YoY | +9533.3% QoQ)
Original exchange filing (PDF)
More announcements from Bafna Pharmaceuticals Ltd
- We herewith enclose the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026 as approved by the Board of Directors in its Meeting held on November 11, 2026. · 11 Nov 2026
- Bafna Pharmaceuticals Limited has submitted to the Exchange, the Outcome of the Board Meeting held on 11/11/2026 along with the Unaudited Financial Results and Limited Review Report issued by the Statutory Auditors, for the Quarter and Half Year ended September 30, 2026. · 11 Nov 2026
- To consider and approve the Un-Audited Financial Results for the Quarter and Half Year ended September 30, 2026 · 11 Nov 2026
- BAFNA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 11-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 11 Nov 2026
- Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve the Un-Audited Financial .... · 11 Nov 2026
- We herewith enclose the Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report. · 11 Sept 2026
- We herewith enclose the Outcome / Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026. · 11 Sept 2026
- We herewith enclose the Notice of 31st Annual General Meeting of the Company scheduled to be held on Friday, September 11, 2026 at 10.00 A.M along with the Annual Report of the Company .... · 20 Aug 2026
